Feiba

Product Specs	Description
Manufacturer Name	Takeda
Indications	For use in hemophilia A and B patients with inhibitors for: Control and prevention of bleeding episodes Perioperative management Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
Contraindications	Patients who havea history of anaphylactic or severe hypersensitivity reactions to FEIBA or any of its components, including factors of the kinin generating system, disseminated intravascular coagulation (DIC) or acute thrombosis or embolism (including myocardial infarction).
Viral Safety Process	Vapor heat treatment and 35 nm nanofiltration
Product Half-Life	N/A; Dosing intervals: 6-12 hours by type of hemorrhage
Manufacturing Method	Plasma Derived
Storage Requirements/Shelf Life	Store at 36°F to 77°F (2°C to 25°C) Store in the original package to protect from light. Do not freeze. Prior to preparation and reconstitution, allow the vials to reach room temperature, if refrigerated.
Nominal Vial Size & Diluent Volume	500 or 1000 IU/20 mL 2500 IU/50 mL

About